Bond Vet and Small Door Merge to Form a VC-Backed Alternative to the PE Vet Roll-Up

Bond Vet and Small Door merge into a 55-clinic network

The combined company spans more than 55 clinics across the Northeast, Mid-Atlantic, and Midwest, serving over 500,000 pets with 1,000-plus employees, including more than 170 veterinarians. Financial terms were not disclosed.

Small Door co-founder Florent Peyre becomes CEO of the merged organization. Joe Altobelli, Bond Vet's president and CFO, shifts to executive strategic advisor. Small Door's chief medical officer, Dr. Jamie Richardson, keeps that role across the full network.

In the near term, both brands keep their names, locations, and care teams, with a unified experience to follow.

The two came up on the same thesis: vet care built like modern consumer healthcare. Small Door, founded in 2018, runs 13 membership-based clinics on a $149-a-year model with 24/7 telemedicine, transparent pricing, and AAHA accreditation. Bond Vet, founded in 2019, grew to more than 45 clinics offering primary, urgent, dental, and surgical care.

They often operate in the same neighborhoods, which makes this as much a consolidation of overlapping urban footprints as a push into new ones.

Why premium vets are consolidating without selling to PE

Corporate and private-equity ownership has climbed from roughly 8% of U.S. clinics in 2011 to about half by 2025, per veterinary consolidation trackers. That growth came almost entirely through the roll-up: a PE-backed platform (Mars, Ethos, PetVet, Thrive) buying independent practices a few at a time and folding them into shared back-office infrastructure.

This deal doesn't fit that mold. Two brands that raised venture money to build a differentiated experience merged with each other, horizontally, rather than exiting to a platform. It echoes the 2024 merger of mobile-vet startups The Vets and BetterVet, but brings the same logic to brick-and-mortar clinics. That distinction matters for operators weighing their own path.

The capital math frames the stakes. Bond Vet raised roughly $243 million, anchored by a $170 million growth investment from Warburg Pincus in 2021 and a $50 million round in 2023. Small Door raised north of $100 million across its Series A, a $40 million Series B in 2022, and a $55 million round in 2025 led by Valspring Capital.

The companies did not disclose terms. What's clear is the shape of the move: two well-capitalized brands choosing to combine rather than raise again or sell into a platform, building scale in a financing market that has turned cautious on both.

Leadership signals the direction. Peyre, running the smaller brand by clinic count, takes CEO, while Bond's finance chief moves to an advisory seat. The membership model, not the urgent-care footprint, appears to be the organizing spine of the combined company. That's a bet that recurring revenue and relationship continuity, the things Small Door sells, travel better than location density.

It also lands against a softer backdrop for the roll-up. S&P cut Thrive Pet Healthcare to CCC+ in early 2025 and called its capital structure likely unsustainable. The FTC, meanwhile, has started scrutinizing vet deals, forcing divestitures and pre-clearance conditions on the largest buyers. Scale still wins in vet care, but the debt-heavy version of scale is under more pressure than it was two years ago, and a merger of near-equals sidesteps some of it.

What integration and regulators will test next

Integration is the near-term tell. Watch whether "operate as separate brands for now" holds or quietly collapses into one. Two overlapping urban networks create obvious savings in real estate, staffing, and marketing, and the pressure to capture them usually beats the promise to preserve both identities. The place to look is any neighborhood where Bond and Small Door sit blocks apart.

The second test is the model itself. Bond runs a walk-in, urgent-and-primary footprint; Small Door runs annual memberships. Merging them means deciding whether Bond's clients get pushed toward paid membership, and whether that lifts or dents the net promoter scores both brands market on.

The third is regulatory. At 55 clinics the combined company sits well below the scale that has drawn FTC action, but the agency's growing interest in local vet-market concentration makes dense-market overlap worth tracking, especially if the company keeps buying.

For operators, the signal is the structure as much as the size. The venture-funded tier of vet care now has a consolidation path that doesn't end on a PE platform's balance sheet. Whether it produces better economics than the roll-up it's reacting to is the question the next year will answer.

Source: Bond Vet and Small Door Veterinary Merge to Expand Access to Trusted Veterinary Care, via PR Newswire